Enablement of RAASi therapy in HF using novel potassium binders
10' education - Mar. 8, 2022 - Prof. Javed Butler, MD (Jackson, MS, USA) and prof. Giuseppe Rosano, MD, PhD (London, UK)Video navigation menu
The problem of RAASi therapy and incidence of hyperkalemia 00:50
Study data on potassium binders 05:02
Considerations for long term management with potassium binders 07:35
Take-home message 11:33
Educational information
This video was developed by our partner, ReachMD, a leading online learning platform for physicians and other healthcare professionals.
Faculty
Javed Butler, MD is professor and chairman of the Department of Medicine at the University of Mississippi, Jackson, MS, USA.
Giuseppe Rosano, MD, PhD is professor of cardiology and consultant cardiologist at St. George's University Hospitals in London, UK.
Disclosures
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of EPCCS.
Funding
Funding for this educational program was provided by and independent educational grant from Vifor Pharma.
Click here for the CME course on ReachMD
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: